Amatoxin-derived payloads and their antibody-drug conjugate: unique bicyclopeptide ADCs exhibiting targeted antitumor activity
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Meiyu Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Key Laboratory of Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Inner Mong…. Hauptthemen laut MEDLINE: Immunoconjugates, Antineoplastic Agents, Amanitins, Peptides, Cyclic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Inner Mongolia Autonomous Region People's Government, National Natural Science Foundation of China.
Abstract (Originalsprache)
Balancing efficacy with off-target toxicity remains a critical challenge in the development of antibody-drug conjugates (ADCs). Emerging ADC technologies, including the design of safer payloads and optimized drug-linkers, offer new avenues to improve both safety and efficacy. Amatoxins bind efficiently to eukaryotic RNA polymerase II at nanomolar concentrations, potently inhibiting transcription and subsequent protein synthesis. In this study, we designed, synthesized, and evaluated a series of novel amatoxin-based bicyclic peptide payloads. From these, three payload-linkers incorporating a Val-Ala (VA) peptide linker were generated, and two trastuzumab-based ADCs (O-3-ADC and P-3-ADC) were constructed. A novel synthetic strategy was developed in which p-aminobenzyl alcohol (PABC) was first coupled to the amatoxin-derived payload, followed by amide bond formation with the VA linker. In vitro cytotoxicity assays revealed that O-3-ADC exhibited IC₅₀ values of 8.5 ± 0.06 nM and 20 ± 0.41 nM against HeLa and SK-OV-3 cells, respectively, while P-3-ADC showed IC₅₀ values of 7.5 ± 0.04 nM and 27 ± 0.12 nM against the same cell lines. Compared to their corresponding free payloads, the antitumor activity of the two novel ADCs was enhanced by up to 255-fold. Furthermore, P-3-ADC significantly inhibited tumor growth in vivo. Collectively, these results demonstrate that the novel amatoxin-derived payloads and their corresponding ADCs possess significant antitumor potential, highlighting their promise for future targeted ADC development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inner Mongolia Key Laboratory of Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Inner Mongolia University (South Campus), 24 Zhaojun Road, Hohhot 010030, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, 4090 Susong Rd, Hefei 230601, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, 4090 Susong Rd, Hefei 230601, China; Anhui University of Chinese Medicine First Clinical Medical College, Hefei 230038, China.
- Institute of Health and Medicine, Hefei Comprehensive National Science Center, 4090 Susong Rd, Hefei 230601, China; Anhui University of Chinese Medicine First Clinical Medical College, Hefei 230038, China. Electronic ad…
- Inner Mongolia Key Laboratory of Synthesis and Application of Organic Functional Molecules, College of Chemistry and Chemical Engineering, Inner Mongolia University (South Campus), 24 Zhaojun Road, Hohhot 010030, China;…
Förderung
- National Key Research and Development Program of China
- Inner Mongolia Autonomous Region People's Government
- National Natural Science Foundation of China
- Inner Mongolia Autonomous Region Department of Science and Technology
- Natural Science Foundation of Inner Mongolia Autonomous Region
- Inner Mongolia University
- Inner Mongolia University of Technology
- Science and Technology Major Project of Inner Mongolia Autonomous Region of China
Zitieren
APA
Wang, M., Gu, M., Guo, Y., Wang, J., Zhang, C., Wang, Y., Yan, Y., Ke, J., & Liu, G. (2026). Amatoxin-derived payloads and their antibody-drug conjugate: unique bicyclopeptide ADCs exhibiting targeted antitumor activity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109754
Vancouver
Wang M, Gu M, Guo Y, Wang J, Zhang C, Wang Y, et al. Amatoxin-derived payloads and their antibody-drug conjugate: unique bicyclopeptide ADCs exhibiting targeted antitumor activity. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109754
BibTeX
@article{Wang2026,
author = {Wang, Meiyu and Gu, Mingzhen and Guo, Yanyan and Wang, Jiao and Zhang, Cunxi and Wang, Yahua and Yan, Yinglu and Ke, Jiyuan and Liu, Guodu},
title = {Amatoxin-derived payloads and their antibody-drug conjugate: unique bicyclopeptide ADCs exhibiting targeted antitumor activity},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109754}
}
EUVIMED